[HTML][HTML] Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives

GK Efthimiadis, ED Pagourelias, T Gossios… - World journal of …, 2014 - ncbi.nlm.nih.gov
Hypertrophic cardiomyopathy (HCM), the most variable cardiac disease in terms of
phenotypic presentation and clinical outcome, represents the most common inherited …

Temporal trend of age at diagnosis in hypertrophic cardiomyopathy: an analysis of the international sarcomeric human cardiomyopathy registry

M Canepa, C Fumagalli, G Tini… - Circulation: Heart …, 2020 - Am Heart Assoc
Background: Over the last 50 years, the epidemiology of hypertrophic cardiomyopathy
(HCM) has changed because of increased awareness and availability of advanced …

[HTML][HTML] Гипертрофическая кардиомиопатия. Клинические рекомендации 2020

СА Габрусенко, АЯ Гудкова… - Российский …, 2021 - cyberleninka.ru
Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …

Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction

GK Efthimiadis, ED Pagourelias, D Parcharidou… - Circulation …, 2013 - jstage.jst.go.jp
Background: The prevalence, clinical characteristics and natural history of patients with
hypertrophic cardiomyopathy (HCM) and midventricular obstruction (MVO) have not been …

[HTML][HTML] 2020 Clinical practice guidelines for Hypertrophic cardiomyopathy

SA Gabrusenko, AY Gudkova… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
: hypertrophic cardiomyopathy, obstructive hypertrophic cardiomyopathy, hypertrophic
cardiomyopathy phenocopies, sarcomeric mutations, familial genetic screening, sudden …

Clinical Characteristics and Healthcare Resource Utilization among Patients with Obstructive Hypertrophic Cardiomyopathy Treated in a Range of Settings in the …

M Butzner, E Rowin, A Yakubu, J Seale… - Journal of Clinical …, 2022 - mdpi.com
Obstructive hypertrophic cardiomyopathy (oHCM) has been studied primarily in
comprehensive centers of excellence. Broadening the understanding of patients with oHCM …

Clinical characteristics and prognosis of 60 patients with midventricular obstructive hypertrophic cardiomyopathy

L Yan, S Zhao, H Wang, F Duan, Z Wang… - Journal of …, 2015 - journals.lww.com
Background Midventricular obstructive hypertrophic cardiomyopathy (MVOHCM) is a rare
form of hypertrophic cardiomyopathy. Knowledge regarding the diagnosis, morbidity and …

[PDF][PDF] 左心室中部肥厚型梗阻性心肌病的临床特点及预后

安硕研, 樊朝美, 赵世华, 田月琴, 刘延玲… - Chinese Circulation …, 2015 - nccd.org.cn
摘要目的: 本研究旨在探究左心室中部肥厚型梗阻性心肌病(MVOHCM) 患者的临床特点及长期
预后. 方法: 对66 例MVOHCM 患者的发病率, 临床特征, 心血管事件发生率和死亡率进行了回顾 …

[HTML][HTML] Significance and Frequency of Incidental Fortuitous Clinical Identifications of Hypertrophic Cardiomyopathy

S Abraham, EJ Rowin, AM Saji, JS Silver, PS Shekar… - JACC: Advances, 2024 - jacc.org
2 general medical settings. Most commonly, these were unexpected precordial murmurs or
electrocardiogram abnormalities, but also less frequent circumstances such as insurance or …

Ренин-ангиотензин-альдостероновая система при гипертрофической кардиомиопатии

МВ Кожевникова, ВЮ Каплунова, ЕВ Привалова… - Кардиология, 2014 - elibrary.ru
С целью изучения роли ренин-ангиотензин-альдостероновой системы (РААС) в
формировании клинических вариантов течения гипертрофической кардиомиопатии …